The FDA approved Regeneron's Otarmeni on April 23, making it the first gene therapy for inherited hearing loss — and ...

The FDA has approved Otarmeni, the first-ever gene therapy for genetic hearing loss caused by the OTOF gene, for both ...

Kelly Anne is a deputy editor at Forbes Advisor overseeing the development of various initiatives, including newsletters, social media, and new content verticals. Previously, she worked as a senior ...

A first-of-its-kind gene therapy that can restore hearing in children born deaf has just cleared its final hurdle—and, in a ...

Researchers say a gene therapy allowed deaf children and adults as old as 32 to hear for the first time. The benefits have ...

Regeneron will make its newly approved gene therapy available for free in the U.S. The company hasn't yet decided how much it ...

An experimental gene therapy for a rare form of genetic deafness has successfully restored hearing in children and adults, ...

The treatment, developed by Regeneron Pharmaceuticals, is for a very rare form of deafness. But it represents a medical ...

When Santa Claus brought 10-year-old Kathy High a junior chemistry set for Christmas more than 60 years ago, he never could’ve imagined what an incredible gift he was giving her. And ...

The US Food and Drug Administration on Thursday approved the first gene therapy for inherited hearing loss, a one-time ...

The treatment, the first of its kind, was approved by the Food and Drug Administration on Thursday. “Our baby was born deaf, ...

FDA approves Otarmeni gene therapy for genetic hearing loss; Regeneron offers free treatment, restoring hearing by correcting ...